Patent US2379022A successfully refreshed from Google Patents.
Patent US6005087A successfully refreshed from Google Patents.
US6005087A
Expired / Lapsed
US
⏱️ 0.0 years remaining
2'-modified oligonucleotides
Assignee: Ionis Pharmaceuticals Inc
•
Filing: 1998-03-05
•
Granted: 1999-12-21
•
Expires: 2018-03-05
Abstract
Abstract Compositions and methods are provided for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the 2'-deoxyfuranosyl moieties of the nucleoside unit is modified. Treatment of diseases caused by various viruses and other causative agents is provided.
Inventors
- 👤 Phillip Dan Cook
- 👤 Andrew Mamoru Kawasaki
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 22:27
CPC Classifications
C; C07; C07H; C07H21/00; C07H21/04; A; A61; A61K; A61K31/00; A61K31/70; A61K31/7088; A61K31/7125; C07H19/00; C07H19/02; C07H19/04; C07H19/06; C07H19/10; C07H19/16; C07H19/20; C07H23/00; C07J; C07J43/00; C07J43/003; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/111; C12N15/113; C12N15/1137; C12N9/00; C12N9/0004; C12N9/0069; C12Q; C12Q1/00; C12Q1/68; C12Y; C12Y113/00; C12Y113/11; C12Y113/11012; A61K38/00; A61K48/00; C12N2310/00; C12N2310/10; C12N2310/11; C12N2310/30; C12N2310/31; C12N2310/312; C12N2310/3125; C12N2310/315; C12N2310/32; C12N2310/321; C12N2310/322; C12N2310/33; C12N2310/333; C12N2310/336; C12N2310/35; C12N2310/352; C12N2310/3521; C12N2310/3523; C12N2310/3527; C12N2310/353; C12N2310/3531; C12N2310/3533
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
78 words
A compound comprising a plurality of covalently-bound nucleosides that individually include a ribose or deoxyribose sugar portion and a base portion, wherein: said nucleosides are joined together by internucleoside linkages such that the base portion of said nucleosides form a mixed base sequence; at least one of said nucleosides includes a modified ribofuranosyl moiety bearing a 2'-fluoro substituent; provided that at least two of said nucleosides are 2-fluoro modified ribofuranosyl nucleosides when said internucleoside linkages are phosphodiester linkages.
Claim 2
Dependent Claim
78 words
A compound comprising a plurality of covalently-bound nucleosides that individually include a ribose or deoxyribose sugar portion and a base portion, wherein: said nucleosides are joined together by internucleoside linkages such that the base portion of said nucleosides form a mixed base sequence; at least one of said nucleosides includes a modified ribofuranosyl moiety bearing a 2'-fluoro substituent; provided that at least two of said nucleosides are 2-fluoro modified ribofuranosyl nucleosides when said internucleoside linkages are phosphodiester linkages.
Claim 3
Dependent Claim
12 words
The compound of claim 1 having 5 to 50 nucleoside linked nucleosides.
Claim 4
Dependent Claim
24 words
The compound of claim 1 wherein at least two of said nucleosides are covalently bound through phosphorothioate, methyl phosphonate, or phosphate alkylate internucleoside linkages.
References Cited (Backward Citations)
US4381344A
Cited
US4511713A
Cited
US4689320A
Cited
US4965350A
Cited
US4760017A
Cited
US4876335A
Cited
US5013830A
Cited
EP0260032A2
Cited
EP0269574A2
Cited
EP0287313A2
Cited
EP0339330A2
Cited
EP0339842A2
Cited
DE3915462A1
Cited
EP0399330A1
Cited
CA2017369A1
Cited
WO1990015814A1
Cited
US5134066A
Cited
EP0417999A1
Cited
WO1991006556A1
Cited
US5466786B1
Cited
US5466786A
Cited
WO1991010671A1
Cited
US5212295A
Cited
WO1991015499A1
Cited
US5658731A
Cited
US5138045A
Cited
US5378825A
Cited
WO1992002258A1
Cited
WO1992003568A1
Cited
US5223618A
Cited
US5672695A
Cited
WO1992007065A1
Cited
US5698687A
Cited
DE4110085A1
Cited
WO1992022651A1
Cited
US5214135A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-12-20 | 2003-06-21 | 2003-12-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-12-20 | 2007-06-21 | 2007-12-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-12-20 | 2011-06-21 | 2011-12-21 | $7700.00 | Window Closed / Lapsed |